BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18195096)

  • 21. Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients.
    Trentin L; Giordan M; Dingermann T; Basso G; Te Kronnie G; Marschalek R
    Eur J Haematol; 2009 Nov; 83(5):406-19. PubMed ID: 19558506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).
    Ono R; Taki T; Taketani T; Taniwaki M; Kobayashi H; Hayashi Y
    Cancer Res; 2002 Jul; 62(14):4075-80. PubMed ID: 12124344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rearrangement of the myeloid/lymphoid leukemia gene in therapy-related myelodysplastic syndrome in patients previously treated with agents targeting DNA topoisomerase II.
    Mosad E; Abdou M; Zaky AH
    Oncology; 2012; 83(3):128-34. PubMed ID: 22814291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two consecutive immunophenotypic switches in a child with MLL-rearranged acute lymphoblastic leukemia.
    Germano G; Pigazzi M; del Giudice L; Campo Dell'Orto M; Spinelli M; Zangrando A; Paolucci P; Ladogana S; Basso G
    Haematologica; 2006 May; 91(5 Suppl):ECR09. PubMed ID: 16709517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia.
    Tsujioka T; Wada H; Yamamori S; Otsuki T; Suemori S; Kondo T; Nakanishi H; Suetsugu Y; Mikami M; Sugihara T
    Int J Hematol; 2003 Dec; 78(5):439-42. PubMed ID: 14704037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.
    Cowell IG; Sondka Z; Smith K; Lee KC; Manville CM; Sidorczuk-Lesthuruge M; Rance HA; Padget K; Jackson GH; Adachi N; Austin CA
    Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8989-94. PubMed ID: 22615413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity.
    Betti CJ; Villalobos MJ; Jiang Q; Cline E; Diaz MO; Loredo G; Vaughan AT
    Leukemia; 2005 Dec; 19(12):2289-95. PubMed ID: 16193084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23).
    Dahéron L; Veinstein A; Brizard F; Drabkin H; Lacotte L; Guilhot F; Larsen CJ; Brizard A; Roche J
    Genes Chromosomes Cancer; 2001 Aug; 31(4):382-9. PubMed ID: 11433529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner.
    Hayette S; Cornillet-Lefebvre P; Tigaud I; Struski S; Forissier S; Berchet A; Doll D; Gillot L; Brahim W; Delabesse E; Magaud JP; Rimokh R
    Cancer Res; 2005 Aug; 65(15):6521-5. PubMed ID: 16061630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A complex t(1;22;11)(q44;q13;q23) translocation causing MLL-p300 fusion gene in therapy-related acute myeloid leukemia.
    Ohnishi H; Taki T; Yoshino H; Takita J; Ida K; Ishii M; Nishida K; Hayashi Y; Taniwaki M; Bessho F; Watanabe T
    Eur J Haematol; 2008 Dec; 81(6):475-80. PubMed ID: 18778367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
    Xie W; Tang G; Wang E; Kim Y; Cloe A; Shen Q; Zhou Y; Garcia-Manero G; Loghavi S; Hu AY; Wang S; Bueso-Ramos CE; Kantarjian HM; Medeiros LJ; Hu S
    Ann Hematol; 2020 Mar; 99(3):487-500. PubMed ID: 32006151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Panhandle PCR approaches to cloning MLL genomic breakpoint junctions and fusion transcript sequences.
    Robinson BW; Felix CA
    Methods Mol Biol; 2009; 538():85-114. PubMed ID: 19277575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a chromosomal breakpoint and detection of a novel form of an MLL-AF17 fusion transcript in acute monocytic leukemia with t(11;17)(q23;q21).
    Suzukawa K; Shimizu S; Nemoto N; Takei N; Taki T; Nagasawa T
    Int J Hematol; 2005 Jul; 82(1):38-41. PubMed ID: 16105757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
    J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
    Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
    Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
    Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
    Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma.
    Whittle SB; Punia JN; López-Terrada D; Gaikwad A; Hampton OA; Heczey A
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e486-e488. PubMed ID: 28902076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPHN, a novel partner gene fused to MLL in a leukemia with t(11;14)(q23;q24).
    Eguchi M; Eguchi-Ishimae M; Seto M; Morishita K; Suzuki K; Ueda R; Ueda K; Kamada N; Greaves M
    Genes Chromosomes Cancer; 2001 Nov; 32(3):212-21. PubMed ID: 11579461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryptic splice site activation during RNA processing of MLL/AF4 chimeric transcripts in infants with t(4;11) positive ALL.
    Divoky V; Trka JM; Watzinger F; Lion T
    Gene; 2000 Apr; 247(1-2):111-8. PubMed ID: 10773450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.